Company Overview

Healwell AI Inc. is a Canadian healthcare artificial intelligence company focused on improving disease detection, clinical decision support, and preventative care through data-driven technologies. The company operates at the intersection of healthcare services, medical data, and artificial intelligence, primarily targeting early identification of chronic and rare diseases. Its core value proposition is leveraging large-scale patient data and proprietary algorithms to assist physicians, healthcare systems, and life sciences organizations in improving diagnostic accuracy and patient outcomes.

The company generates revenue through a combination of AI-enabled clinical software, healthcare services, and data analytics offerings, with a strategic emphasis on preventative care and early diagnosis. Healwell AI evolved through a series of acquisitions and platform integrations rather than organic product development alone, positioning itself as a consolidator of healthcare data assets and AI capabilities. The company was incorporated in 2017 and later listed on the Toronto Stock Exchange under the symbol AIDX, expanding its scope through targeted investments in healthcare technology and services businesses.

Business Operations

Healwell AI operates through multiple business lines centered on AI & Data Science, Healthcare Services, and Clinical Decision Support, generating revenue from software licensing, data analytics contracts, and healthcare service delivery. A significant portion of its operations is conducted through wholly owned subsidiaries that provide access to longitudinal patient data, physician networks, and AI-enabled tools designed to identify gaps in care and disease risk. These operations support pharmaceutical companies, insurers, and healthcare providers seeking insights from real-world evidence and predictive analytics.

The company maintains domestic operations in Canada and international activities primarily in the United States and Europe, reflecting its focus on markets with established electronic health record infrastructure. Healwell AI controls proprietary data assets, machine learning models, and physician-facing platforms, often integrating them into clinical workflows. Its operating structure includes technology development entities and healthcare service providers, with notable subsidiaries such as Pentavere Research Group, Orion Health Holdings Canada, and Intrahealth Systems, each contributing specialized data, AI, or interoperability capabilities.

Strategic Position & Investments

Healwell AI’s strategy centers on becoming a leading AI-driven preventative healthcare platform, with growth driven by acquisitions, technology integration, and expansion of its data ecosystem. The company has made significant investments in acquiring established healthcare software and data businesses to accelerate commercialization and broaden its addressable market. Acquisitions such as Pentavere Research Group and Intrahealth Systems have expanded its presence in AI-driven clinical research and healthcare interoperability, while Orion Health Holdings Canada strengthened its enterprise healthcare software footprint.

The company is also positioned within emerging healthcare sectors such as real-world evidence generation, precision medicine, and population health management, where demand for AI-enhanced analytics continues to grow. Healwell AI has articulated a strategy focused on long-term value creation through scalable platforms, recurring software revenue, and partnerships with healthcare institutions and life sciences companies, rather than reliance on one-time technology deployments.

Geographic Footprint

Healwell AI is headquartered in Toronto, Ontario, Canada, and maintains a primary operational presence across Canada and the United States, which together represent its largest markets. These regions are central to the company’s strategy due to regulatory frameworks that support data-driven healthcare innovation and the widespread adoption of electronic medical records. The company also has operational and customer exposure in Europe, particularly through legacy assets and software platforms serving national and regional healthcare systems.

The company’s international footprint reflects its focus on developed healthcare markets with large patient populations and complex data environments. While Canada remains a strategic base for corporate leadership and public market access, Healwell AI’s growth initiatives increasingly emphasize cross-border data analytics and enterprise healthcare software opportunities in North America and select international jurisdictions.

Leadership & Governance

Healwell AI was founded by entrepreneur Hamed Shahbazi, who has played a central role in shaping the company’s acquisition-led growth strategy and long-term vision. The leadership team emphasizes disciplined capital allocation, data governance, and collaboration with healthcare providers as core elements of its operating philosophy. Governance practices align with requirements for publicly listed Canadian companies, with oversight from an independent board of directors.

Key executives include:

• Hamed Shahbazi – Chief Executive Officer
• James Lee – Chief Financial Officer
• Dr. Alexander Dobranowski – Chief Medical Officer
• Mark Lethbridge – President, Data Science and AI
• Scott McGowan – Chief Operating Officer

The leadership team’s strategic vision centers on using AI to shift healthcare systems from reactive treatment toward proactive and preventative care, while building an integrated platform capable of supporting clinicians, researchers, and healthcare enterprises at scale.